Publications

Prof. Dr. rer. nat. Yvonne Döring

2021

Sundararaman SS, Peters LJF, Jansen Y, Gencer S, Yan Y, Nazir S, Bonnin Marquez A, Kahles F, Lehrke M, Biessen EAL, Jankowski J, Weber C, Döring Y, van der Vorst EPC. Adipocyte calcium sensing receptor is not involved in visceral adipose tissue inflammation or atherosclerosis development in hyperlipidemic Apoe^-/- mice. Sci Rep. 2021 May 17;11(1):10409. doi: 10.1038/s41598-021-89893-y. PMID: 34001955; PMCID: PMC8128899.

van der Vorst EPC, Döring Y. Tracing Endothelial CXCR4 May Pave the Way for Localized Lesional Treatment Approaches. Arterioscler Thromb Vasc Biol. 2021 Feb;41(2):837-838. doi: 10.1161/ATVBAHA.120.315781. Epub 2021 Jan 27. PMID: 33955781.

Gencer S, Döring Y, Jansen Y, Bayasgalan S, Schengel O, Müller M, Peters LJF, Weber C, van der Vorst EPC. Adipocyte-Specific ACKR3 Regulates Lipid Levels in Adipose Tissue. Biomedicines. 2021 Apr 6;9(4):394. doi: 10.3390/biomedicines9040394. PMID: 33917642; PMCID: PMC8067615.

Kou J, Wang M, Shi J, Zhang H, Pu X, Song S, Yang C, Yan Y, Döring Y, Xie X, Pang X. Curcumin Reduces Cognitive Deficits by Inhibiting Neuroinflammation through the Endoplasmic Reticulum Stress Pathway in Apolipoprotein E4 Transgenic Mice. ACS Omega. 2021 Mar 2;6(10):6654-6662. doi: 10.1021/acsomega.0c04810. PMID: 33748578; PMCID: PMC7970496.

Gencer S, Evans BR, van der Vorst EPC, Döring Y, Weber C. Inflammatory Chemokines in Atherosclerosis. Cells. 2021 Jan 25;10(2):226. doi: 10.3390/cells10020226. PMID: 33503867; PMCID: PMC7911854.

Schumski A, Ortega-Gómez A, Wichapong K, Winter C, Lemnitzer P, Viola JR, Pinilla-Vera M, Folco E, Solis-Mezarino V, Völker-Albert M, Maas SL, Pan C, Perez Olivares L, Winter J, Hackeng T, Karlsson MCI, Zeller T, Imhof A, Baron RM, Nicolaes GAF, Libby P, Maegdefessel L, Kamp F, Benoit M, Döring Y, Soehnlein O. Endotoxinemia Accelerates Atherosclerosis Through Electrostatic Charge-Mediated Monocyte Adhesion. Circulation. 2021 Jan 19;143(3):254-266. doi: 10.1161/CIRCULATIONAHA.120.046677. Epub 2020 Nov 10. PMID: 33167684; PMCID: PMC7914394.

2020

Gencer S, Lacy M, Atzler D, van der Vorst EPC, Döring Y, Weber C. Immunoinflammatory, Thrombohaemostatic, and Cardiovascular Mechanisms in COVID-19. Thromb Haemost. 2020 Dec;120(12):1629-1641. doi: 10.1055/s-0040-1718735. Epub 2020 Oct 29. PMID: 33124029; PMCID: PMC7869061.

Döring Y, Noels H, van der Vorst E, Weber C. Seeing is repairing: how imaging-based timely interference with CXCR4 could improve repair after myocardial infarction. Eur Heart J. 2020 Oct 1;41(37):3576-3578. doi: 10.1093/eurheartj/ehaa625. PMID: 32918455.

Kiouptsi K, Pontarollo G, Todorov H, Braun J, Jäckel S, Koeck T, Bayer F, Karwot C, Karpi A, Gerber S, Jansen Y, Wild P, Ruf W, Daiber A, Van Der Vorst E, Weber C, Döring Y, Reinhardt C. Germ-free housing conditions do not affect aortic root and aortic arch lesion size of late atherosclerotic low-density lipoprotein receptor-deficient mice. Gut Microbes. 2020 Nov 1;11(6):1809-1823. doi: 10.1080/19490976.2020.1767463. Epub 2020 Jun 24. PMID: 32579470; PMCID: PMC7524356.

Döring Y, Libby P, Soehnlein O. Neutrophil Extracellular Traps Participate in Cardiovascular Diseases: Recent Experimental and Clinical Insights. Circ Res. 2020 Apr 24;126(9):1228-1241. doi: 10.1161/CIRCRESAHA.120.315931. Epub 2020 Apr 23. PMID: 32324499; PMCID: PMC7185047.

Eckardt V, Miller MC, Blanchet X, Duan R, Leberzammer J, Duchene J, Soehnlein O, Megens RT, Ludwig AK, Dregni A, Faussner A, Wichapong K, Ippel H, Dijkgraaf I, Kaltner H, Döring Y, Bidzhekov K, Hackeng TM, Weber C, Gabius HJ, von Hundelshausen P, Mayo KH. Chemokines and galectins form heterodimers to modulate inflammation. EMBO Rep. 2020 Apr 3;21(4):e47852. doi: 10.15252/embr.201947852. Epub 2020 Feb 21. PMID: 32080959; PMCID: PMC7132340.

Döring Y, Jansen Y, Cimen I, Aslani M, Gencer S, Peters LJF, Duchene J, Weber C, van der Vorst EPC. B-Cell-Specific CXCR4 Protects Against Atherosclerosis Development and Increases Plasma IgM Levels. Circ Res. 2020 Mar 13;126(6):787-788. doi: 10.1161/CIRCRESAHA.119.316142. Epub 2020 Feb 5. PMID: 32078474.

Sternkopf M, Nagy M, Baaten CCFMJ, Kuijpers MJE, Tullemans BME, Wirth J, Theelen W, Mastenbroek TG, Lehrke M, Winnerling B, Baerts L, Marx N, De Meester I, Döring Y, Cosemans JMEM, Daiber A, Steven S, Jankowski J, Heemskerk JWM, Noels H. Native, Intact Glucagon-Like Peptide 1 Is a Natural Suppressor of Thrombus Growth Under Physiological Flow Conditions. Arterioscler Thromb Vasc Biol. 2020 Mar;40(3):e65-e77. doi: 10.1161/ATVBAHA.119.313645. Epub 2020 Jan 2. PMID: 31893947.

van der Vorst EPC, Daissormont I, Aslani M, Seijkens T, Wijnands E, Lutgens E, Duchene J, Santovito D, Döring Y, Halvorsen B, Aukrust P, Weber C, Höpken UE, Biessen EAL. Interruption of the CXCL13/CXCR5 Chemokine Axis Enhances Plasma IgM Levels and Attenuates Atherosclerosis Development. Thromb Haemost. 2020 Feb;120(2):344-347. doi: 10.1055/s-0039-3400746. Epub 2019 Dec 14. PMID: 31837653.

2019

Popper B, Rammer MT, Gasparitsch M, Singer T, Keller U, Döring Y, Lange-Sperandio B. Neonatal obstructive nephropathy induces necroptosis and necroinflammation. Sci Rep. 2019 Dec 9;9(1):18600. doi: 10.1038/s41598-019-55079-w. PMID: 31819111; PMCID: PMC6901532.

Tilstam PV, Soppert J, Hemmers C, Harlacher E, Döring Y, van der Vorst EPC, Schulte C, Alampour-Rajabi S, Theelen W, Asare Y, de Winther MPJ, Lawrence T, Bernhagen J, Schober A, Zernecke A, Jankowski J, Weber C, Noels H. Non-activatable mutant of inhibitor of kappa B kinase α (IKKα) exerts vascular site-specific effects on atherosclerosis in Apoe-deficient mice. Atherosclerosis. 2020 Jan;292:23-30. doi: 10.1016/j.atherosclerosis.2019.10.023. Epub 2019 Nov 2. PMID: 31733453.

Kiouptsi K, Jäckel S, Pontarollo G, Grill A, Kuijpers MJE, Wilms E, Weber C, Sommer F, Nagy M, Neideck C, Jansen Y, Ascher S, Formes H, Karwot C, Bayer F, Kollar B, Subramaniam S, Molitor M, Wenzel P, Rosenstiel P, Todorov H, Gerber S, Walter U, Jurk K, Heemskerk JWM, van der Vorst EPC, Döring Y, Reinhardt C. The Microbiota Promotes Arterial Thrombosis in Low-Density Lipoprotein Receptor-Deficient Mice. mBio. 2019 Oct 22;10(5):e02298-19. doi: 10.1128/mBio.02298-19. PMID: 31641089; PMCID: PMC6805995.

Ferraro B, Leoni G, Hinkel R, Ormanns S, Paulin N, Ortega-Gomez A, Viola JR, de Jong R, Bongiovanni D, Bozoglu T, Maas SL, D'Amico M, Kessler T, Zeller T, Hristov M, Reutelingsperger C, Sager HB, Döring Y, Nahrendorf M, Kupatt C, Soehnlein O. Pro-Angiogenic Macrophage Phenotype to Promote Myocardial Repair. J Am Coll Cardiol. 2019 Jun 18;73(23):2990-3002. doi: 10.1016/j.jacc.2019.03.503. PMID: 31196457.

van der Vorst EPC, Peters LJF, Müller M, Gencer S, Yan Y, Weber C, Döring Y. G-Protein Coupled Receptor Targeting on Myeloid Cells in Atherosclerosis. Front Pharmacol. 2019 May 22;10:531. doi: 10.3389/fphar.2019.00531. PMID: 31191301; PMCID: PMC6540917.

Lutgens E, Atzler D, Döring Y, Duchene J, Steffens S, Weber C. Immunotherapy for cardiovascular disease. Eur Heart J. 2019 Dec 21;40(48):3937-3946. doi: 10.1093/eurheartj/ehz283. PMID: 31121017.

Döring Y, van der Vorst EPC, Duchene J, Jansen Y, Gencer S, Bidzhekov K, Atzler D, Santovito D, Rader DJ, Saleheen D, Weber C. CXCL12 Derived From Endothelial Cells Promotes Atherosclerosis to Drive Coronary Artery Disease. Circulation. 2019 Mar 5;139(10):1338-1340. doi: 10.1161/CIRCULATIONAHA.118.037953. PMID: 30865486; PMCID: PMC6417827.

van der Vorst EPC, Mandl M, Müller M, Neideck C, Jansen Y, Hristov M, Gencer S, Peters LJF, Meiler S, Feld M, Geiselhöringer AL, de Jong RJ, Ohnmacht C, Noels H, Soehnlein O, Drechsler M, Weber C, Döring Y. Hematopoietic ChemR23 (Chemerin Receptor 23) Fuels Atherosclerosis by Sustaining an M1 Macrophage-Phenotype and Guidance of Plasmacytoid Dendritic Cells to Murine Lesions-Brief Report. Arterioscler Thromb Vasc Biol. 2019 Apr;39(4):685-693. doi: 10.1161/ATVBAHA.119.312386. Erratum in: Arterioscler Thromb Vasc Biol. 2020 Oct;40(10):e274. PMID: 30786742.

Gencer S, van der Vorst EPC, Aslani M, Weber C, Döring Y, Duchene J. Atypical Chemokine Receptors in Cardiovascular Disease. Thromb Haemost. 2019 Apr;119(4):534-541. doi: 10.1055/s-0038-1676988. Epub 2019 Feb 4. PMID: 30716778.

2018

Döring Y, van der Vorst EPC. Gouty Offense in Patients With Obstructive Coronary Artery Disease Despite State-of-the-Art Therapy. J Am Heart Assoc. 2018 Aug 21;7(16):e010322. doi: 10.1161/JAHA.118.010322. PMID: 30369331; PMCID: PMC6201402.

van der Vorst EPC, Döring Y. Resistin keeps its Janus face. Int J Cardiol. 2018 Dec 1;272:47-48. doi: 10.1016/j.ijcard.2018.08.071. Epub 2018 Aug 28. PMID: 30180984.

Paulin N, Viola JR, Maas SL, de Jong R, Fernandes-Alnemri T, Weber C, Drechsler M, Döring Y, Soehnlein O. Double-Strand DNA Sensing Aim2 Inflammasome Regulates Atherosclerotic Plaque Vulnerability. Circulation. 2018 Jul 17;138(3):321-323. doi: 10.1161/CIRCULATIONAHA.117.033098. PMID: 30012706.

Schumski A, Winter C, Döring Y, Soehnlein O. The Ins and Outs of Myeloid Cells in Atherosclerosis. J Innate Immun. 2018;10(5-6):479-486. doi: 10.1159/000488091. Epub 2018 Apr 18. PMID: 29669334; PMCID: PMC6784034.

Rami M, Guillamat-Prats R, Rinne P, Salvermoser M, Ring L, Bianchini M, Blanchet X, Megens RTA, Döring Y, Walzog B, Soehnlein O, Weber C, Faussner A, Steffens S. Chronic Intake of the Selective Serotonin Reuptake Inhibitor Fluoxetine Enhances Atherosclerosis. Arterioscler Thromb Vasc Biol. 2018 May;38(5):1007-1019. doi: 10.1161/ATVBAHA.117.310536. Epub 2018 Mar 22. PMID: 29567680.

Merckelbach S, van der Vorst EPC, Kallmayer M, Rischpler C, Burgkart R, Döring Y, de Borst GJ, Schwaiger M, Eckstein HH, Weber C, Pelisek J. Expression and Cellular Localization of CXCR4 and CXCL12 in Human Carotid Atherosclerotic Plaques. Thromb Haemost. 2018 Jan;118(1):195-206. doi: 10.1160/TH17-04-0271. Epub 2018 Jan 5. PMID: 29304539.

Prof. Dr. med. Iris Baumgartner

2021

Hsia J, Kavanagh ST, Hopley CW, Baumgartner I, Berger JS, Fowkes GR, Jones WS, Mahaffey KW, Norgren L, Patel MR, Rockhold F, Blomster J, Katona BG, Hiatt WR, Bonaca MP. Impact of chronic kidney disease on hemoglobin among patients with peripheral artery disease treated with P2Y₁₂ inhibitors: Insights from the EUCLID trial. Vasc Med. 2021 Jun 3:1358863X211017641. doi: 10.1177/1358863X211017641. Epub ahead of print. PMID: 34082620.

Samsky MD, Hellkamp A, Hiatt WR, Fowkes FGR, Baumgartner I, Berger JS, Katona BG, Mahaffey KW, Norgren L, Blomster JI, Rockhold FW, DeVore AD, Patel MR, Jones WS. Association of Heart Failure With Outcomes Among Patients With Peripheral Artery Disease: Insights From EUCLID. J Am Heart Assoc. 2021 Jun 15;10(12):e018684. doi: 10.1161/JAHA.120.018684. Epub 2021 May 31. PMID: 34056910.

Krogager ML, Kragholm K, Thomassen JQ, Søgaard P, Lewis BS, Wassmann S, Baumgartner I, Ceconi C, Schmidt TA, Kaski JC, Drexel H, Semb AG, Agewall S, Niessner A, Savarese G, Kjeldsen KP, Borghi C, Tamargo J, Torp-Pedersen C. Update on management of hypokalemia and goals for the lower potassium level in patients with cardiovascular disease: A review in collaboration with the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy. Eur Heart J Cardiovasc Pharmacother. 2021 May 6:pvab038. doi: 10.1093/ehjcvp/pvab038. Epub ahead of print. PMID: 33956964.

Galani J, Mulder H, Rockhold FW, Weissler EH, Baumgartner I, Berger JS, Blomster JI, Fowkes FGR, Hiatt WR, Katona BG, Norgren L, Mahaffey KW, Quint JK, Patel MR, Jones WS. Association of Chronic Obstructive Pulmonary Disease with Morbidity and Mortality in Patients with Peripheral Artery Disease: Insights from the EUCLID Trial. Int J Chron Obstruct Pulmon Dis. 2021 Mar 29;16:841-851. doi: 10.2147/COPD.S292978. PMID: 33824584; PMCID: PMC8018572.

Rössler J, Baselga E, Davila V, Celis V, Diociaiuti A, El Hachem M, Mestre S, Haeberli D, Prokop A, Hanke C, Loichinger W, Quéré I, Baumgartner I, Niemeyer CM, Kapp FG. Severe adverse events during sirolimus "off-label" therapy for vascular anomalies. Pediatr Blood Cancer. 2021 Aug;68(8):e28936. doi: 10.1002/pbc.28936. Epub 2021 Feb 13. PMID: 33580918.

Dopheide JF, Adam L, Wiedmer S, Kaspar M, Silbernagel G, Baumgartner I, Drexel H. Improved lipid target level attainment in patients with peripheral artery disease. Curr Vasc Pharmacol. 2021 Jan 11. doi: 10.2174/1570161119666210111123621. Epub ahead of print. PMID: 33430734.

2020

Kochar A, Mulder H, Rockhold FW, Baumgartner I, Berger JS, Blomster JI, Fowkes FGR, Katona BG, Lopes RD, Al-Khalidi HR, Mahaffey KW, Norgren L, Hiatt WR, Patel MR, Jones WS. Cause of Death Among Patients With Peripheral Artery Disease: Insights From the EUCLID Trial. Circ Cardiovasc Qual Outcomes. 2020 Nov;13(11):e006550. doi: 10.1161/CIRCOUTCOMES.120.006550. Epub 2020 Nov 12. PMID: 33176462.

Haine A, Rosenov A, Mertineit N, Baumgartner I, Schindewolf M. Catheter Directed Thrombectomy Under Temporary Catheter Based Filter Protection in Renal Vein Thrombosis and Contraindication to Anticoagulation. EJVES Vasc Forum. 2020 Sep 19;49:16-19. doi: 10.1016/j.ejvsvf.2020.09.001. PMID: 33089223; PMCID: PMC7560707.

Rymer JA, Mulder H, Narcisse DI, Rockhold F, Hiatt WR, Fowkes FG, Baumgartner I, Berger JS, Katona BG, Mahaffey K, Norgren L, Blomster JI, Jones WS, Patel MR. Association of Disease Progression With Cardiovascular and Limb Outcomes in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial. Circ Cardiovasc Interv. 2020 Oct;13(10):e009326. doi: 10.1161/CIRCINTERVENTIONS.120.009326. Epub 2020 Oct 12. PMID: 33040584.

Gutierrez JA, Heizer GM, Jones WS, Rockhold FW, Mahaffey KW, Fowkes FGR, Berger JS, Baumgartner I, Held P, Katona BG, Norgren L, Blomster JI, Hiatt WR, Patel MR. CYP2C19 status and risk of major adverse cardiovascular events in peripheral artery disease: Insights from the EUCLID Trial. Am Heart J. 2020 Nov;229:118-120. doi: 10.1016/j.ahj.2020.07.017. Epub 2020 Aug 16. PMID: 32950849.

Rymer JA, Mulder H, Smolderen KG, Hiatt WR, Conte MS, Berger JS, Norgren L, Mahaffey KW, Baumgartner I, Fowkes FG, Katona BG, Rockhold F, Jones WS, Patel MR. Association of Health Status Scores With Cardiovascular and Limb Outcomes in Patients With Symptomatic Peripheral Artery Disease: Insights From the EUCLID (Examining Use of Ticagrelor in Symptomatic Peripheral Artery Disease) Trial. J Am Heart Assoc. 2020 Oct 20;9(19):e016573. doi: 10.1161/JAHA.120.016573. Epub 2020 Sep 13. PMID: 32924754; PMCID: PMC7792388.

Kohi MP, Brodmann M, Zeller T, Micari A, Baumgartner I, Wang H, Wall B, Razavi MK. Sex-Related Differences in the Long-Term Outcomes of Patients with Femoropopliteal Arterial Disease Treated with the IN.PACT Drug-Coated Balloon in the IN.PACT SFA Randomized Controlled Trial: A Post Hoc Analysis. J Vasc Interv Radiol. 2020 Sep;31(9):1410-1418.e10. doi: 10.1016/j.jvir.2020.05.012. PMID: 32868016.

Fudim M, Hopley CW, Huang Z, Kavanagh S, Rockhold FW, Baumgartner I, Berger JS, Blomster JI, Fowkes FGR, Katona BG, Mahaffey KW, Norgren L, Ostrom C, Patel MR, Jones WS, Hiatt WR. Association of Hypertension and Arterial Blood Pressure on Limb and Cardiovascular Outcomes in Symptomatic Peripheral Artery Disease: The EUCLID Trial. Circ Cardiovasc Qual Outcomes. 2020 Sep;13(9):e006512. doi: 10.1161/CIRCOUTCOMES.120.006512. Epub 2020 Aug 31. PMID: 32862697.

Long CA, Mulder H, Fowkes FGR, Baumgartner I, Berger JS, Katona BG, Mahaffey KW, Norgren L, Blomster JI, Rockhold FW, Hiatt WR, Patel MR, Jones WS, Nehler MR. Incidence and Factors Associated With Major Amputation in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial. Circ Cardiovasc Qual Outcomes. 2020 Jul;13(7):e006399. doi: 10.1161/CIRCOUTCOMES.119.006399. Epub 2020 Jul 3. PMID: 32615798.

Sebastian T, Barco S, Engelberger RP, Spirk D, Schindewolf M, Baumann F, Baumgartner I, Kucher N. Duplex Ultrasound Investigation for the Detection of Obstructed Iliocaval Venous Stents. Eur J Vasc Endovasc Surg. 2020 Sep;60(3):443-450. doi: 10.1016/j.ejvs.2020.05.011. Epub 2020 Jun 27. PMID: 32605854.

Vuillemin N, Bernhard S, Haine A, Schindewolf M, Häberli D, Hügel U, Obrist D, Baumgartner I. Capillary-venule malformation is a microfistulous variant of arteriovenous malformation. J Vasc Surg Venous Lymphat Disord. 2021 Jan;9(1):220-225. doi: 10.1016/j.jvsv.2020.05.012. Epub 2020 May 26. PMID: 32470616.

Dopheide JF, Ramadani H, Adam L, Gahl B, Papac L, Veit J, Kaspar M, Schindewolf M, Baumgartner I, Drexel H. Development of a 3-Dimensional Prognostic Score for Patients With Symptomatic Peripheral Artery Disease: PAD^3D Score. Angiology. 2020 Aug;71(7):658-665. doi: 10.1177/0003319720920155. Epub 2020 Apr 28. PMID: 32342699.

Terlouw LG, Moelker A, Abrahamsen J, Acosta S, Bakker OJ, Baumgartner I, Boyer L, Corcos O, van Dijk LJ, Duran M, Geelkerken RH, Illuminati G, Jackson RW, Kärkkäinen JM, Kolkman JJ, Lönn L, Mazzei MA, Nuzzo A, Pecoraro F, Raupach J, Verhagen HJ, Zech CJ, van Noord D, Bruno MJ. European guidelines on chronic mesenteric ischaemia - joint United European Gastroenterology, European Association for Gastroenterology, Endoscopy and Nutrition, European Society of Gastrointestinal and Abdominal Radiology, Netherlands Association of Hepatogastroenterologists, Hellenic Society of Gastroenterology, Cardiovascular and Interventional Radiological Society of Europe, and Dutch Mesenteric Ischemia Study group clinical guidelines on the diagnosis and treatment of patients with chronic mesenteric ischaemia. United European Gastroenterol J. 2020 May;8(4):371-395. doi: 10.1177/2050640620916681. Epub 2020 Apr 16. PMID: 32297566; PMCID: PMC7226699.

Rosenov A, Schindewolf M, Baumgartner I, Saely C. Selective Arterial Embolizations of Renal Angiomyolipomas Using 96% Ethanol: A Case Series of 5 Patients. Clin Med Insights Case Rep. 2020 Feb 17;13:1179547620906863. doi: 10.1177/1179547620906863. PMID: 32110130; PMCID: PMC7026809.

Zeller T, Micari A, Scheinert D, Baumgartner I, Bosiers M, Vermassen FEG, Banyai M, Shishehbor MH, Wang H, Brodmann M; IN.PACT DEEP Trial Investigators. The IN.PACT DEEP Clinical Drug-Coated Balloon Trial: 5-Year Outcomes. JACC Cardiovasc Interv. 2020 Feb 24;13(4):431-443. doi: 10.1016/j.jcin.2019.10.059. PMID: 32081236.

Haine A, Kavanagh S, Berger JS, Hess CN, Norgren L, Fowkes FGR, Katona BG, Mahaffey KW, Blomster JI, Patel MR, Jones WS, Rockhold FW, Hiatt WR, Baumgartner I; International Steering Committee and Investigators of the EUCLID Trial. Sex-Specific Risks of Major Cardiovascular and Limb Events in Patients With Symptomatic Peripheral Artery Disease. J Am Coll Cardiol. 2020 Feb 18;75(6):608-617. doi: 10.1016/j.jacc.2019.11.057. PMID: 32057375.

Baumgartner I, Schindewolf M. The paclitaxel story in cardiovascular medicine. Eur Heart J. 2020 Oct 7;41(38):3740-3742. doi: 10.1093/eurheartj/ehz881. PMID: 31951252.

Heiss C, Pitcher A, Belch JJF, De Carlo M, Reinecke H, Baumgartner I, Mazzolai L, Aboyans V. The year in cardiology: aorta and peripheral circulation. Eur Heart J. 2020 Jan 21;41(4):501-508b. doi: 10.1093/eurheartj/ehz939. PMID: 31901938.

2019

Dopheide JF, Veit J, Ramadani H, Adam L, Papac L, Vonbank A, Kaspar M, Rastan A, Baumgartner I, Drexel H. Adherence to statin therapy favours survival of patients with symptomatic peripheral artery disease. Eur Heart J Cardiovasc Pharmacother. 2019 Dec 10:pvz081. doi: 10.1093/ehjcvp/pvz081. Epub ahead of print. PMID: 31886861.

Ward R, Huang Z, Rockhold FW, Baumgartner I, Berger JS, Blomster JI, Fowkes FGR, Katona BG, Mahaffey KW, Norgren L, Vemulapalli S, Povsic TJ, Mehta R, Hiatt WR, Patel MR, Jones WS. Major bleeding in patients with peripheral artery disease: Insights from the EUCLID trial. Am Heart J. 2020 Feb;220:51-58. doi: 10.1016/j.ahj.2019.11.007. Epub 2019 Nov 18. PMID: 31783279.

Haine A, Schmid MJ, Schindewolf M, Lenz A, Bernhard SM, Drexel H, Baumgartner I, Dopheide JF. Comparison Between Interwoven Nitinol and Drug Eluting Stents for Endovascular Treatment of Femoropopliteal Artery Disease. Eur J Vasc Endovasc Surg. 2019 Dec;58(6):865-873. doi: 10.1016/j.ejvs.2019.09.002. Epub 2019 Oct 25. PMID: 31668949.

Agnelli G, Belch JJF, Baumgartner I, Giovas P, Hoffmann U. Morbidity and mortality associated with atherosclerotic peripheral artery disease: A systematic review. Atherosclerosis. 2020 Jan;293:94-100. doi: 10.1016/j.atherosclerosis.2019.09.012. Epub 2019 Sep 24. PMID: 31606132.

Kansal A, Huang Z, Rockhold FW, Baumgartner I, Berger JS, Blomster JI, Fowkes FG, Katona B, Mahaffey KW, Norgren L, Hiatt WR, Patel MR, Jones WS. Impact of Procedural Bleeding in Peripheral Artery Disease: An Analysis From EUCLID Trial. Circ Cardiovasc Interv. 2019 Oct;12(10):e008069. doi: 10.1161/CIRCINTERVENTIONS.119.008069. Epub 2019 Oct 4. PMID: 31581789.

Rosenov A, Hügel U, Baumgartner I, Thalhammer C. Farbkodierte Duplexsonografie der Gefässe in der Praxis: Pitfalls. Praxis (Bern 1994). 2019 Sep;108(12):807-813. German. doi: 10.1024/1661-8157/a003295. PMID: 31530132.

Oshin O, Varcoe R, Wong J, Burrows S, Altaf N, Schlaich M, Weerasooriya R, Gray W, Deloose K, Baumgartner I, Mwipatayi BP. Multivariable Analysis of Patients With Severe Persistent Postprocedural Hypotension After Carotid Artery Stenting. J Endovasc Ther. 2019 Dec;26(6):759-767. doi: 10.1177/1526602819869929. Epub 2019 Aug 21. PMID: 31431153.

Savarese G, Reiner MF, Uijl A, D'Amario D, Agewall S, Atar D, Baumgartner I, Borghi C, De Carlo M, Drexel H, Kaski JC, Kjeldsen KP, Kucher N, Lund LH, Niessner A, Semb AG, Schmidt TA, Sulzgruber P, Tamargo J, Vitale C, Wassmann S, Aboyans V, Lewis BS. Antithrombotic therapy and major adverse limb events in patients with chronic lower extremity arterial disease: systematic review and meta-analysis from the European Society of Cardiology Working Group on Cardiovascular Pharmacotherapy in Collaboration with the European Society of Cardiology Working Group on Aorta and Peripheral Vascular Diseases. Eur Heart J Cardiovasc Pharmacother. 2020 Apr 1;6(2):86-93. doi: 10.1093/ehjcvp/pvz036. PMID: 31392312.

Hügel U, Rosenov A, Baumgartner I, Thalhammer C. Farbkodierte Duplexsonografie der Gefässe in der Praxis: Artefakte [Vascular Color-Coded Duplex Ultrasound in Practice: Artifacts]. Praxis (Bern 1994). 2019 Aug;108(10):679-684. German. doi: 10.1024/1661-8157/a003276. PMID: 31387491.

Hopley CW, Kavanagh S, Patel MR, Ostrom C, Baumgartner I, Berger JS, Blomster JI, Fowkes FGR, Jones WS, Katona BG, Mahaffey KW, Norgren L, Rockhold FW, Hiatt WR. Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial. Vasc Med. 2019 Oct;24(5):422-430. doi: 10.1177/1358863X19864172. Epub 2019 Jul 24. PMID: 31339474.

Huegel U, Baumgartner I. Implementation of new endovenous treatments in therapy for lateral embryonic veins. J Vasc Surg Cases Innov Tech. 2019 Jun 25;5(3):243-247. doi: 10.1016/j.jvscit.2018.12.016. PMID: 31304432; PMCID: PMC6600075.

Hess CN, Huang Z, Patel MR, Baumgartner I, Berger JS, Blomster JI, Fowkes FGR, Held P, Jones WS, Katona B, Mahaffey KW, Norgren L, Rockhold FW, Hiatt WR. Acute Limb Ischemia in Peripheral Artery Disease. Circulation. 2019 Aug 13;140(7):556-565. doi: 10.1161/CIRCULATIONAHA.119.039773. Epub 2019 Jun 26. PMID: 31238713.

Amberger H, Baumgartner I, Kucher N, Schindewolf M. Endovascular port-a-cath rescue in acute thrombotic superior vena cava syndrome. J Vasc Surg Cases Innov Tech. 2019 May 22;5(2):169-173. doi: 10.1016/j.jvscit.2019.03.005. PMID: 31193522; PMCID: PMC6535642.

Tuleja A, Baumgartner I, Schindewolf M. Claudication Caused By Stenosis of Arteria Lusoria-Case Report and Review of Literature. Clin Med Insights Case Rep. 2019 Apr 18;12:1179547619842187. doi: 10.1177/1179547619842187. PMID: 31037038; PMCID: PMC6475851.

Thalhammer C, Baumgartner I. Nicht invasive Diagnostik bei Manifestationen der Arteriosklerose [Non-Invasive Diagnostics of Arteriosclerotic Manifestations]. Dtsch Med Wochenschr. 2019 Mar;144(5):308-314. German. doi: 10.1055/a-0657-1628. Epub 2019 Mar 5. PMID: 30836401.

Olivier CB, Mulder H, Hiatt WR, Jones WS, Fowkes FGR, Rockhold FW, Berger JS, Baumgartner I, Held P, Katona BG, Norgren L, Blomster J, Patel MR, Mahaffey KW. Incidence, Characteristics, and Outcomes of Myocardial Infarction in Patients With Peripheral Artery Disease: Insights From the EUCLID Trial. JAMA Cardiol. 2019 Jan 1;4(1):7-15. doi: 10.1001/jamacardio.2018.4171. PMID: 30540355; PMCID: PMC6439683.

PD Dr. med. Marc Schindewolf

2021

Sebastian T, Barco S, Lichtenberg M, Stahlhoff S, Schlager O, Jalaie H, de Graaf R, Erbel C, Massmann A, Schindewolf M, Kucher N. Twelve-month clinical outcomes of a hybrid oblique self-expanding nitinol stent used for the treatment of post-thrombotic syndrome with common iliac vein compression: The TOPOS study. Vasc Med. 2021 Jun 16:1358863X211017658. doi: 10.1177/1358863X211017658. Epub ahead of print. PMID: 34130569.

Mosler F, Richter JK, Schindewolf M, Mertineit N, Tengg-Kobligk HV, Heverhagen JT, Nöldge G. Ionic and non-ionic intravenous X-ray contrast media: antibacterial agents? Acta Radiol. 2021 May 30:2841851211019804. doi: 10.1177/02841851211019804. Epub ahead of print. PMID: 34056917.

2020

Haine A, Rosenov A, Mertineit N, Baumgartner I, Schindewolf M. Catheter Directed Thrombectomy Under Temporary Catheter Based Filter Protection in Renal Vein Thrombosis and Contraindication to Anticoagulation. EJVES Vasc Forum. 2020 Sep 19;49:16-19. doi: 10.1016/j.ejvsvf.2020.09.001. PMID: 33089223; PMCID: PMC7560707.

Agnelli G, Hoffmann U, Hainaut P, Gaine S, Ay C, Coppens M, Schindewolf M, Jimenez D, Brüggenjürgen B, Levy P, Laeis P, Fronk EM, Zierhut W, Malzer T, Manu MC, Reimitz PE, Bramlage P, Cohen AT; ETNA-VTE-Europe investigators. ETNA-VTE Europe: Benefits and risks of venous thromboembolism treatment using edoxaban in the first 3 months. Thromb Res. 2020 Dec;196:297-304. doi: 10.1016/j.thromres.2020.09.001. Epub 2020 Sep 12. PMID: 32950897.

Cohen AT, Hoffmann U, Hainaut P, Gaine S, Ay C, Coppens M, Schindewolf M, Jimenez D, Brüggenjürgen B, Levy P, Laeis P, Fronk EM, Zierhut W, Malzer T, Manu MC, Reimitz PE, Bramlage P, Agnelli G; ETNA-VTE-Europe investigators. ETNA VTE Europe: A contemporary snapshot of patients treated with edoxaban in clinical practice across eight European countries. Eur J Intern Med. 2020 Dec;82:48-55. doi: 10.1016/j.ejim.2020.08.014. Epub 2020 Aug 18. PMID: 32826158.

Schindewolf M, Beyer-Westendorf J, Balradj J, Bowrin K, Huelsebeck M, Briere JB. Systematic Literature Review of Randomized Trials Comparing Antithrombotic Therapy Following Revascularization Procedures in Patients With Peripheral Artery Disease. Angiology. 2020 Oct;71(9):773-790. doi: 10.1177/0003319720936505. Epub 2020 Jul 8. PMID: 32638610.

Sebastian T, Barco S, Engelberger RP, Spirk D, Schindewolf M, Baumann F, Baumgartner I, Kucher N. Duplex Ultrasound Investigation for the Detection of Obstructed Iliocaval Venous Stents. Eur J Vasc Endovasc Surg. 2020 Sep;60(3):443-450. doi: 10.1016/j.ejvs.2020.05.011. Epub 2020 Jun 27. PMID: 32605854.

Vuillemin N, Bernhard S, Haine A, Schindewolf M, Häberli D, Hügel U, Obrist D, Baumgartner I. Capillary-venule malformation is a microfistulous variant of arteriovenous malformation. J Vasc Surg Venous Lymphat Disord. 2021 Jan;9(1):220-225. doi: 10.1016/j.jvsv.2020.05.012. Epub 2020 May 26. PMID: 32470616.

Dopheide JF, Ramadani H, Adam L, Gahl B, Papac L, Veit J, Kaspar M, Schindewolf M, Baumgartner I, Drexel H. Development of a 3-Dimensional Prognostic Score for Patients With Symptomatic Peripheral Artery Disease: PAD^3D Score. Angiology. 2020 Aug;71(7):658-665. doi: 10.1177/0003319720920155. Epub 2020 Apr 28. PMID: 32342699.

Sebastian T, Lichtenberg M, Schlager O, Jalaie H, de Graaf R, Erbel C, Massmann A, Schindewolf M, Grigorean A, Kucher N. Early clinical outcomes for treatment of post-thrombotic syndrome and common iliac vein compression with a hybrid Oblique self-expanding nitinol stent - the TOPOS study. Vasa. 2020 Jun;49(4):301-308. doi: 10.1024/0301-1526/a000857. Epub 2020 Apr 6. PMID: 32248759.

Rosenov A, Schindewolf M, Baumgartner I, Saely C. Selective Arterial Embolizations of Renal Angiomyolipomas Using 96% Ethanol: A Case Series of 5 Patients. Clin Med Insights Case Rep. 2020 Feb 17;13:1179547620906863. doi: 10.1177/1179547620906863. PMID: 32110130; PMCID: PMC7026809.

Baumgartner I, Schindewolf M. The paclitaxel story in cardiovascular medicine. Eur Heart J. 2020 Oct 7;41(38):3740-3742. doi: 10.1093/eurheartj/ehz881. PMID: 31951252.

Schindewolf M, Weitz JI. Broadening the Categories of Patients Eligible for Extended Venous Thromboembolism Treatment. Thromb Haemost. 2020 Jan;120(1):14-26. doi: 10.1055/s-0039-3400302. Epub 2019 Dec 13. PMID: 31858522.

2019

Haine A, Schmid MJ, Schindewolf M, Lenz A, Bernhard SM, Drexel H, Baumgartner I, Dopheide JF. Comparison Between Interwoven Nitinol and Drug Eluting Stents for Endovascular Treatment of Femoropopliteal Artery Disease. Eur J Vasc Endovasc Surg. 2019 Dec;58(6):865-873. doi: 10.1016/j.ejvs.2019.09.002. Epub 2019 Oct 25. PMID: 31668949.

Amberger H, Baumgartner I, Kucher N, Schindewolf M. Endovascular port-a-cath rescue in acute thrombotic superior vena cava syndrome. J Vasc Surg Cases Innov Tech. 2019 May 22;5(2):169-173. doi: 10.1016/j.jvscit.2019.03.005. PMID: 31193522; PMCID: PMC6535642.

Tuleja A, Baumgartner I, Schindewolf M. Claudication Caused By Stenosis of Arteria Lusoria-Case Report and Review of Literature. Clin Med Insights Case Rep. 2019 Apr 18;12:1179547619842187. doi: 10.1177/1179547619842187. PMID: 31037038; PMCID: PMC6475851.

2018

Schindewolf M. Fondaparinux in heparin-induced thrombocytopenia: A decade's worth of clinical experience. Res Pract Thromb Haemost. 2018 Dec 4;3(1):9-11. doi: 10.1002/rth2.12169. PMID: 30656269; PMCID: PMC6332747.

Saely CH, Schindewolf M, Zanolin D, Heinzle CF, Vonbank A, Silbernagel G, Leiherer A, Drexel H, Baumgartner I. Data on the impact of peripheral artery disease and of type 2 diabetes mellitus on the risk of cardiovascular events. Data Brief. 2018 Nov 3;21:1716-1720. doi: 10.1016/j.dib.2018.10.153. PMID: 30505906; PMCID: PMC6249514.

Saely CH, Schindewolf M, Zanolin D, Heinzle CF, Vonbank A, Silbernagel G, Leiherer A, Drexel H, Baumgartner I. Single and combined effects of peripheral artery disease and of type 2 diabetes mellitus on the risk of cardiovascular events: A prospective cohort study. Atherosclerosis. 2018 Dec;279:32-37. doi: 10.1016/j.atherosclerosis.2018.09.031. Epub 2018 Oct 6. PMID: 30399464.

Schindewolf M, Banik N, Lindhoff-Last E. Reply: Fondaparinux and Direct Oral Anticoagulants: Promising Anticoagulant for Management of Heparin-Induced Thrombocytopenia. J Am Coll Cardiol. 2018 Apr 17;71(15):1710-1712. doi: 10.1016/j.jacc.2018.02.026. PMID: 29650128.

Dopheide JF, Papac L, Schindewolf M, Baumgartner I, Drexel H. Poor attainment of lipid targets in patients with symptomatic peripheral artery disease. J Clin Lipidol. 2018 May-Jun;12(3):711-717. doi: 10.1016/j.jacl.2018.02.013. Epub 2018 Mar 1. PMID: 29574071.

Schindewolf M, Fuss T, Fink H, Gemperli A, Haine A, Baumgartner I. Efficacy Outcomes of Endovascular Versus Surgical Revascularization in Critical Limb Ischemia: Results From a Prospective Cohort Study. Angiology. 2018 Sep;69(8):677-685. doi: 10.1177/0003319717750486. Epub 2018 Jan 21. PMID: 29355026.

Kohler C, Fuss T, Schweizer R, Baumgartner I, Kucher N, Schindewolf M. Haemostaseological complication management in caval and iliac venous stenting. Vasa. 2018 Apr;47(3):243-246. doi: 10.1024/0301-1526/a000686. Epub 2018 Jan 16. PMID: 29336234.